NUWE Nuwellis, Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ 10-K/10-Q Ağu 13, 2026
$0,32
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,1252 haftanın en düşüğü
$6,4052 haftanın en yükseği
Piyasa Değeri (MRQ)
$185.0K
P/E (TTM)
0.0
Hisse Başına Kâr (TTM)
$7.46
Gelir (TTM)
$9M
rozetleriniz
52 Haftlık Aralık
$0–$6
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
·
P/E
0.0
ROE
205.6%
Net Kâr Marjı
-125.6%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NUWE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.32
Piyasa Değeri (MRQ)
$185.0K
P/E (TTM)
0.0
Hisse Başına Kâr (TTM)
$7.46
Gelir (TTM)
$9M
ROE (TTM)
205.6%
52 Haftlık Aralık
$0–$6
NUWE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 26 Haziran 2026 | 1-for-35 | Ters |
| 07 Temmuz 2025 | 1-for-42 | Ters |
| 28 Haziran 2024 | 1-for-35 | Ters |
| 12 Aralık 2022 | 1-for-100 | Ters |
| 19 Ekim 2020 | 1-for-30 | Ters |
| 03 Ocak 2019 | 1-for-14 | Ters |
| 13 Ekim 2017 | 1-for-20 | Ters |
| 13 Ocak 2017 | 1-for-30 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$8M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-25.392020-12-31 → 2025-12-31
Serbest Nakit Akışı$-11M2016-12-31 → 2025-12-31
Net kar marjı-125.6%2017-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NUWE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 0.05Y ort. ≈-155.7 | ≈-155.7 | · | · | |
| F/S (TTM) | 0.05Y ort. ≈44899.5 | ≈44899.5 | 3.9 | Düşük değerli | |
| F/D (MRQ) | -0.15Y ort. ≈14078.9 | ≈14078.9 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.05Y ort. ≈-19682.3 | ≈-19682.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.05Y ort. ≈-19922.6 | ≈-19922.6 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -0.15Y ort. ≈14078.9 | ≈14078.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NUWE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 69.7%5Y ort. ≈59.1% | ≈59.1% | · | · | |
| Faaliyet Kâr Marjı (TTM) | -142.9%5Y ort. ≈-181.3% | ≈-181.3% | -267.5% | En üst düzey | |
| EBITDA Margin (FAVÖK Marjı) | -134.3%5Y ort. ≈-179.2% | ≈-179.2% | -267.5% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -125.6%5Y ort. ≈-196.9% | ≈-196.9% | -353.2% | En üst düzey | |
| Net Kâr Marjı (TTM) | -125.6%5Y ort. ≈-197.0% | ≈-197.0% | -347.0% | En üst düzey | |
| ROA (TTM) | -123.6%5Y ort. ≈-116.1% | ≈-116.1% | -185.6% | Zayıf | |
| ROE (TTM) | 205.6%5Y ort. ≈-46.1% | ≈-46.1% | -169.3% | En üst düzey | |
| ROIC | -423.4%5Y ort. ≈-279.2% | ≈-279.2% | · | · |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NUWE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 2.05Y ort. ≈4.2 | ≈4.2 | 1.4 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 0.95Y ort. ≈3.4 | ≈3.4 | 0.8 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | NUWE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -5.4%5Y ort. ≈2.3% | ≈2.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | -1.1%5Y ort. ≈2.8% | ≈2.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 2.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | NUWE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 1.05Y ort. ≈0.6 | ≈0.6 | 0.4 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 1.75Y ort. ≈1.5 | ≈1.5 | 2.4 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 5.15Y ort. ≈6.5 | ≈6.5 | 6.2 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$217.6K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-539.9%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-26.64 | $-0.69 | -3740.8% |
| 31 Mart 2026 | May 11, 2026 | $-73.15 | $-35.70 | -104.9% |
| 31 Aralık 2025 | $-52.50 | $-55.69 | 5.7% | |
| 31 Mart 2025 | $-1014.30 | $-1139.54 | 11.0% | |
| 31 Aralık 2024 | $-1029.00 | $-644.74 | -59.6% | |
| 30 Eylül 2024 | $73.08 | $-54.84 | 233.3% | |
| 30 Haziran 2024 | $-791.70 | $-353.22 | -124.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8M | $9M | $9M | $9M | $8M | $7M | $6M | $5M | $4M | $1M | $59.0K | $295.0K | |
| Cost of Revenue | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $713.0K | · | · | |
| Gross Profit | $5M | $6M | $5M | $5M | $4M | $4M | · | · | · | · | · | · | |
| R&D Expense | $3M | $3M | $5M | $4M | $5M | $4M | $5M | $3M | $1M | $8M | $18M | $17M | |
| SG&A Expense | $14M | $13M | $17M | $18M | $19M | $17M | $16M | $15M | $10M | $8M | $8M | $9M | |
| Operating Expenses | $16M | $17M | $23M | $22M | $24M | $21M | $24M | $22M | $18M | $17M | $26M | $26M | |
| Operating Income | $-11M | $-11M | $-18M | $-17M | $-20M | $-17M | $-18M | $-17M | $-15M | $-16M | $-26M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $504.0K | $743.0K | · | |
| Other Non-op | $10.0K | $-80.0K | $154.0K | $75.0K | $-19.0K | $-1.0K | $0 | $10.0K | $1M | $-184.0K | $-749.0K | $-49.0K | |
| Pretax Income | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | $-27M | $-26M | |
| Income Tax | $5.0K | $5.0K | $8.0K | $9.0K | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $-54.0K | $-124.0K | $-249.0K | |
| Net Income | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | · | · | |
| EPS (Basic) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · | |
| EPS (Diluted) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · | |
| Shares (Basic) | 690,145 | 31,601 | 56,126 | 173,846 | 69,000 | 1,649,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 690,145 | 31,601 | 56,126 | 173,846 | 69,000 | 1,649,000 | · | · | · | · | · | · | |
| EBITDA | $-11M | $-11M | $-18M | $-17M | $-19M | $-17M | $-18M | $-17M | $-14M | $-15M | $-26M | $-26M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $5M | $4M | $18M | $9M | $14M | $1M | $5M | $16M | $1M | $23M | $31M | |
| Receivables | $1M | $2M | $2M | $1M | $750.0K | $905.0K | $799.0K | $786.0K | $545.0K | $282.0K | · | $59.0K | |
| Inventory | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $677.0K | · | · | |
| Other Current Assets | $698.0K | $315.0K | $461.0K | $396.0K | $328.0K | $237.0K | $161.0K | $203.0K | $136.0K | $137.0K | $479.0K | $360.0K | |
| Current Assets | $5M | $9M | $8M | $23M | $28M | $19M | $4M | $8M | $18M | $2M | $24M | $32M | |
| PP&E (Net) | $368.0K | $478.0K | $728.0K | $980.0K | $1M | $1M | $991.0K | $536.0K | $570.0K | $540.0K | $535.0K | $661.0K | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | $2M | $1M | |
| Accum. Depreciation | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $785.0K | |
| Goodwill | · | · | · | · | · | · | · | · | $0 | $189.0K | · | · | |
| Intangibles | $0 | · | · | · | · | · | · | · | $0 | $4M | · | · | |
| Other Non-current Assets | $271.0K | $21.0K | $120.0K | $21.0K | $21.0K | · | · | · | · | · | · | · | |
| Total Assets | $6M | $10M | $10M | $25M | $30M | $20M | $6M | $9M | $18M | $7M | $24M | $32M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $862.0K | $2M | $3M | $2M | |
| Current Liabilities | $3M | $3M | $3M | $5M | $3M | $4M | $3M | $3M | $2M | $3M | $8M | $3M | |
| Capital Leases | $67.0K | $307.0K | $544.0K | $760.0K | $956.0K | $55.0K | $261.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $179.0K | $0 | · | $0 | $126.0K | $126.0K | $400.0K | · | |
| Total Liabilities | $3M | $3M | $7M | $12M | $4M | $4M | $4M | $3M | $2M | $5M | $12M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | $4M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Paid-in Capital | $319M | $305M | $291M | $280M | $279M | $250M | $218M | $204M | $197M | $169M | · | · | |
| Retained Earnings | $-316M | $-299M | $-288M | $-267M | $-253M | $-233M | $-218M | $-199M | $-182M | $-169M | $-153M | $-127M | |
| Stockholders' Equity | $3M | $7M | $3M | $12M | $26M | $16M | $2M | $6M | $16M | $2M | $12M | $29M | |
| Liabilities + Equity | $6M | $10M | $10M | $25M | $30M | $20M | $6M | $9M | $18M | $7M | $24M | $32M | |
| Shares Outstanding | 48,112 | 104,142 | 161,925 | 536,394 | 105,376 | 2,736,060 | 155,802 | 513,445 | 271,357 | 38,862 | 611,483 | 16,982,642 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $200.0K | $310.0K | $362.0K | $372.0K | $488.0K | $376.0K | $239.0K | $232.0K | $769.0K | $697.0K | $325.0K | $277.0K | |
| Stock-based Comp | $127.0K | $478.0K | $670.0K | $862.0K | $1M | $1M | $2M | $2M | $499.0K | $949.0K | $2M | $3M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $540.0K | $278.0K | $0 | · | |
| Other Non-cash | · | · | · | $-2M | $-104.0K | $-2M | $-4.0K | $153.0K | $194.0K | · | · | · | |
| Operating Cash Flow | $-11M | $-10M | $-18M | $-15M | $-18M | $-17M | $-16M | $-15M | $-12M | $-16M | $-23M | $-23M | |
| CapEx | $90.0K | $60.0K | $149.0K | $122.0K | $219.0K | $298.0K | $490.0K | $198.0K | $259.0K | $117.0K | $199.0K | $351.0K | |
| Investing Cash Flow | $-90.0K | $-60.0K | $330.0K | $15M | $-16M | $-267.0K | $-490.0K | $-198.0K | $-259.0K | $-4M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $8M | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Issued | $4M | $2M | · | · | · | · | · | · | · | · | $7M | $89.0K | |
| Net Stock Activity | $4M | · | · | · | · | · | · | · | · | · | $7M | $89.0K | |
| Financing Cash Flow | $7M | $11M | $4M | $9M | $28M | $30M | $13M | $5M | $26M | $-1M | · | · | |
| Net Change in Cash | $-4M | $1M | $-14M | $9M | $-6M | $13M | $-4M | $-10M | $14M | $-22M | $-8M | $-23M | |
| Taxes Paid | $7.0K | $7.0K | $12.0K | $9.0K | $11.0K | $10.0K | $4.0K | $2.0K | $6.0K | $47.0K | · | · | |
| Free Cash Flow | $-11M | $-10M | $-18M | $-15M | $-18M | $-17M | $-17M | $-15M | $-12M | $-16M | $-23M | $-23M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-17M | $-24M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 62.0% | 64.9% | 56.2% | 55.7% | 56.7% | · | · | · | · | · | · | · | |
| Operating Margin | -134.3% | -125.7% | -198.9% | -201.0% | -246.5% | -228.8% | -328.5% | -340.9% | -416.9% | -1215.0% | -43996.6% | -8741.4% | |
| Net Margin | -211.9% | -127.8% | -228.0% | -170.0% | -247.2% | -212.8% | -328.7% | -340.8% | -376.6% | · | · | · | |
| Pretax Margin | -211.8% | -127.7% | -227.9% | -169.9% | -247.0% | -212.7% | -328.5% | -340.7% | -376.5% | -1229.3% | -45266.1% | -8758.0% | |
| EBITDA Margin | -134.3% | -125.7% | -198.9% | -196.6% | -240.4% | -223.8% | -324.2% | -336.2% | -395.2% | -1161.0% | -43445.8% | -8647.5% | |
| ROA | -219.3% | -113.7% | -117.3% | -52.7% | -77.6% | -123.6% | -252.0% | -125.1% | -103.2% | · | · | · | |
| ROE | 553.1% | -230.1% | -373.2% | -110.1% | -70.0% | -86.4% | -572.5% | -218.5% | -148.7% | · | · | · | |
| ROIC | -423.4% | -168.4% | -589.9% | -139.0% | -75.3% | -104.4% | -910.2% | -287.1% | -91.3% | -888.4% | -161.2% | -87.4% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.5 | 2.6 | 4.9 | 8.5 | 5.2 | 1.2 | 2.9 | 8.5 | 0.7 | 2.9 | 10.0 | |
| Quick Ratio | 0.9 | 2.7 | 1.8 | 4.1 | 7.5 | 4.3 | 0.6 | 2.2 | 7.7 | 0.5 | 2.9 | 9.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.3 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -31.1 | -34.9 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.9 | 0.5 | 0.3 | 0.3 | 0.6 | 0.8 | 0.4 | 0.3 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | 1.7 | 1.6 | 1.7 | 1.4 | 1.2 | 1.4 | 1.5 | 2.3 | 2.4 | 2.1 | · | · | |
| Receivables Turnover | 5.1 | 4.8 | 5.3 | 7.9 | 9.6 | 8.7 | 7.0 | 7.5 | 8.6 | 7.6 | · | 5.0 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.56 | $1.49 | $0.53 | $23.04 | $2.46 | $5.96 | $0.43 | $11.56 | $4.27 | $2.26 | $0.66 | $1.72 | |
| Revenue / Share | $11.98 | $6.58 | $4.51 | $49.10 | $1.16 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-15.66 | $-7.23 | $-9.13 | $-87.06 | $-2.61 | · | · | · | · | · | · | · | |
| Cash / Share | $0.64 | $1.16 | $0.67 | $33.07 | $2.30 | $5.28 | $0.27 | $10.67 | $4.11 | $1.70 | $1.26 | $1.84 | |
| EPS (TTM) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 | $-10.67 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.4% | -1.4% | 3.8% | 7.8% | 6.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.1% | 3.3% | 6.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.1% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $9M | $9M | $9M | $8M | $7M | $6M | $5M | $4M | $1M | $59.0K | $295.0K | |
| Net Income TTM | $-18M | $-11M | $-20M | $-15M | $-20M | $-16M | $-18M | $-17M | $-13M | $-16M | · | · | |
| Market Cap | $3M | $204M | $4.84B | $8.45B | $1.77T | $2.80T | $17.73T | $15.53T | · | · | · | · | |
| P/E | -0.1 | -0.1 | -2.4 | -188.6 | -587.3 | -96025.3 | · | · | · | · | · | · | |
| P/S | 0.4 | 23.3 | 546.6 | 989.4 | 222938.0 | 376742.3 | 3216634.1 | 3107852.4 | · | · | · | · | |
| P/B | 1.1 | 31.2 | 1620.4 | 684.0 | 68057.7 | 171794.3 | 8907975.0 | 2616753.1 | · | · | · | · | |
| P / Tangible Book | 1.1 | 31.2 | 1620.4 | 684.0 | 68057.7 | 171794.3 | · | · | · | · | · | · | |
| P / Cash Flow | -0.3 | -21.3 | -270.1 | -558.0 | -98763.5 | -169161.2 | -1083086.1 | -1066830.1 | · | · | · | · | |
| P / FCF | -0.3 | -21.1 | -267.9 | -553.5 | -97568.5 | -166173.1 | -1051602.9 | -1052517.0 | · | · | · | · | |
| Earnings Yield | -1459.2% | -757.8% | -42.2% | -0.53% | -0.17% | 0.00% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Cost of Revenue | $471.0K | $719.0K | $770.0K | $772.0K | $767.0K | $837.0K | $967.0K | $711.0K | $720.0K | $666.0K | $1M | $1M | $928.0K | $759.0K | $1M | $806.0K | |
| Gross Profit | $1M | $2M | $2M | $1M | $958.0K | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| R&D Expense | $942.0K | $2M | $884.0K | $603.0K | $675.0K | $550.0K | $831.0K | $486.0K | $558.0K | $1M | $1M | $1M | $2M | $1M | $1M | $928.0K | |
| SG&A Expense | $4M | $5M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $5M | $4M | $3M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $5M | $6M | $4M | $4M | $4M | $4M | $4M | $3M | $4M | $6M | $5M | $5M | $6M | $7M | $6M | $5M | |
| Operating Income | $-3M | $-5M | $-2M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | $-5M | $-4M | $-3M | $-5M | $-6M | $-5M | $-4M | |
| Other Non-op | $7.0K | $1.0K | $-11.0K | $4.0K | $10.0K | $7.0K | $7.0K | $8.0K | $6.0K | $-101.0K | $56.0K | $-204.0K | $179.0K | $123.0K | · | $52.0K | |
| Pretax Income | $-5M | $-5M | $-2M | $468.0K | $-13M | $-3M | $-1M | $2M | $-8M | $-4M | $-6M | $-3M | $-5M | $-6M | $-2M | $-4M | |
| Income Tax | $0 | $0 | $0 | $0 | $4.0K | $1.0K | $1.0K | $0 | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $3.0K | $2.0K | |
| Net Income | $-5M | $-5M | $-2M | $468.0K | $-13M | $-3M | $-1M | $2M | $-8M | $-4M | $-6M | $-3M | $-5M | $-6M | $-2M | $-4M | |
| EPS (Basic) | $-26.64 | $-2.19 | $35.73 | $0.56 | $-2134.19 | $-28.93 | $389.40 | $73.23 | $-791.82 | $-24.11 | $-163.38 | $-63.27 | $-127.65 | $-5.76 | $36.29 | $-36.72 | |
| EPS (Diluted) | $-26.64 | $-2.19 | $35.73 | $0.56 | $-2134.19 | $-28.93 | $389.40 | $73.23 | $-791.82 | $-24.11 | $-163.38 | $-63.27 | $-127.65 | $-5.76 | $36.29 | $-36.72 | |
| Shares (Basic) | 181,243 | 2,074,940 | · | 836,386 | 5,881 | 104,142 | · | 204,710 | 9,755 | 179,608 | · | 53,265 | 37,949 | 1,125,993 | · | 105,000 | |
| Shares (Diluted) | 181,243 | 2,074,940 | · | 836,386 | 5,881 | 104,142 | · | 204,710 | 9,755 | 179,608 | · | 53,265 | 37,949 | 1,125,993 | · | 105,000 | |
| EBITDA | $-3M | $-5M | · | $-3M | $-3M | $-3M | · | $-2M | $-2M | $-5M | · | $-3M | $-5M | $-6M | · | $-4M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $2M | $1M | $3M | $4M | $3M | $5M | $2M | $1M | $1M | $4M | $5M | $9M | $12M | $18M | $12M | |
| Receivables | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | |
| Other Current Assets | $690.0K | $406.0K | $698.0K | $776.0K | $745.0K | $274.0K | $315.0K | $430.0K | $544.0K | $440.0K | $461.0K | $947.0K | $943.0K | $477.0K | $396.0K | $368.0K | |
| Current Assets | $8M | $6M | $5M | $7M | $8M | $6M | $9M | $5M | $5M | $5M | $8M | $10M | $14M | $17M | $23M | $16M | |
| PP&E (Net) | $347.0K | $365.0K | $368.0K | $414.0K | $359.0K | $405.0K | $478.0K | $551.0K | $630.0K | $681.0K | $728.0K | $912.0K | $875.0K | $907.0K | $980.0K | $1M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | $4M | · | · | · | $4M | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | · | $3M | · | |
| Intangibles | $102.0K | $112.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $599.0K | $420.0K | $271.0K | $21.0K | $21.0K | $21.0K | $21.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $106.0K | $21.0K | $21.0K | |
| Total Assets | $9M | $7M | $6M | $8M | $9M | $7M | $10M | $7M | $6M | $7M | $10M | $11M | $16M | $18M | $25M | $18M | |
| Accounts Payable | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $2M | $2M | |
| Current Liabilities | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $4M | |
| Capital Leases | $0 | $0 | $67.0K | $128.0K | $189.0K | $249.0K | $307.0K | $368.0K | $428.0K | $488.0K | $544.0K | $601.0K | $654.0K | $708.0K | $760.0K | $810.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Liabilities | $11M | $4M | $3M | $4M | $18M | $3M | $3M | $4M | $13M | $6M | $7M | $4M | $4M | $5M | $12M | $4M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $0 | $0 | $0 | $0 | $0 | $1.0K | |
| Paid-in Capital | $324M | $324M | $319M | $318M | $305M | $305M | $305M | $301M | $293M | $293M | $291M | $290M | $290M | $288M | $280M | $280M | |
| Retained Earnings | $-326M | $-321M | $-316M | $-314M | $-314M | $-302M | $-299M | $-297M | $-300M | $-292M | $-288M | $-282M | $-279M | $-274M | $-267M | $-266M | |
| Stockholders' Equity | $-2M | $3M | $3M | $4M | $-9M | $4M | $7M | $3M | $-7M | $885.0K | $3M | $8M | $11M | $14M | $12M | $14M | |
| Liabilities + Equity | $9M | $7M | $6M | $8M | $9M | $7M | $10M | $7M | $6M | $7M | $10M | $11M | $16M | $18M | $25M | $18M | |
| Shares Outstanding | 574,455 | 2,635,718 | 1,686,217 | 1,364,970 | 527,158 | 4,373,968 | 104,142 | 1,866,890 | 515,744 | 6,801,443 | 161,925 | 1,864,265 | 1,864,265 | 1,206,932 | 536,394 | 10,537,606 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $37.0K | $38.0K | $34.0K | $43.0K | $50.0K | $73.0K | $83.0K | $76.0K | $75.0K | $76.0K | $109.0K | $84.0K | $83.0K | $86.0K | · | $95.0K | |
| Stock-based Comp | $22.0K | $25.0K | $24.0K | $19.0K | $17.0K | $67.0K | $104.0K | $101.0K | $115.0K | $158.0K | $157.0K | $135.0K | $197.0K | $181.0K | $165.0K | $220.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $112.0K | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | $-3M | $-3M | $-3M | $-4M | $-5M | $-6M | $-3M | $-3M | |
| CapEx | $9.0K | $30.0K | $-12.0K | $98.0K | $4.0K | $0 | $23.0K | $-16.0K | $24.0K | $29.0K | $-36.0K | $121.0K | $51.0K | $13.0K | $19.0K | $22.0K | |
| Investing Cash Flow | $-9.0K | $-284.0K | $12.0K | $-98.0K | $-4.0K | $0 | $-23.0K | $16.0K | $-24.0K | $-29.0K | $36.0K | $-121.0K | $513.0K | $-98.0K | $15M | $-22.0K | |
| Stock Issued | · | $4M | $0 | $0 | $4M | $0 | $0 | $0 | · | · | · | $-2M | · | · | · | $0 | |
| Net Stock Activity | · | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $4M | $1M | $2M | $4M | $0 | $5M | $3M | $2M | $500.0K | $2M | $-20.0K | $2M | $-11.0K | $9M | $-15.0K | |
| Net Change in Cash | $2M | $999.0K | $-2M | $-1M | $2M | $-3M | $3M | $884.0K | $-377.0K | $-2M | $-1M | $-4M | $-3M | $-6M | $21M | $-3M | |
| Free Cash Flow | · | $-3M | · | · | · | $-3M | · | · | · | $-3M | · | · | · | $-6M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.1% | 70.1% | · | 65.2% | 55.5% | 56.0% | · | 70.0% | 67.2% | 64.1% | · | 57.3% | 55.3% | 58.4% | · | 61.0% | |
| Operating Margin | -160.9% | -190.1% | · | -121.6% | -168.5% | -160.7% | · | -64.7% | -105.7% | -255.7% | · | -131.2% | -242.0% | -320.4% | · | -189.8% | |
| Net Margin | -245.2% | -189.0% | · | 21.1% | -727.7% | -158.3% | · | 99.6% | -352.1% | -233.2% | · | -139.7% | -233.5% | -355.1% | · | -187.4% | |
| Pretax Margin | -245.2% | -189.0% | · | 21.1% | -727.5% | -158.2% | · | 99.6% | -352.0% | -233.1% | · | -139.6% | -233.4% | -355.0% | · | -187.3% | |
| EBITDA Margin | -160.9% | -190.1% | · | -121.6% | -168.5% | -160.7% | · | -64.7% | -105.7% | -255.7% | · | -131.2% | -242.0% | -315.7% | · | -189.8% | |
| ROA | -52.7% | -65.0% | · | 6.4% | -163.1% | -44.1% | · | 26.0% | -71.1% | -34.4% | · | -22.6% | -25.8% | -29.1% | · | -14.7% | |
| ROE | 87.7% | -145.6% | · | 13.2% | 158.9% | -135.1% | · | 42.8% | -364.6% | -59.5% | · | -30.8% | -33.7% | -36.7% | · | -17.6% | |
| ROIC | 154.2% | -171.7% | · | -69.0% | 32.4% | -85.5% | · | -48.2% | 34.0% | -536.9% | · | -40.4% | -45.4% | -42.8% | · | -28.0% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.6 | · | 2.0 | 2.2 | 2.2 | · | 2.0 | 1.2 | 1.2 | · | 3.2 | 3.6 | 4.0 | · | 4.6 | |
| Quick Ratio | 1.4 | 1.0 | · | 1.2 | 1.4 | 1.5 | · | 1.2 | 0.6 | 0.6 | · | 2.1 | 2.6 | 3.1 | · | 3.6 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.2 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.4 | 1.6 | · | 1.8 | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.5 | · | 1.9 | 1.7 | 1.6 | · | 1.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-3.58 | $1.01 | · | $2.86 | $-17.00 | $0.82 | · | $1.70 | $-13.25 | $0.13 | · | $4.20 | $5.94 | $11.32 | · | $1.33 | |
| Revenue / Share | $10.86 | $1.16 | · | $2.65 | $8.38 | $0.44 | · | $1.75 | $5.36 | $0.30 | · | $1.29 | $1.56 | $1.62 | · | $0.20 | |
| Cash Flow / Share | · | $-1.50 | · | · | · | $-0.58 | · | · | · | $-0.46 | · | · | · | $-5.42 | · | · | |
| Cash / Share | $6.83 | $0.79 | · | $2.27 | $8.44 | $0.58 | · | $1.02 | $1.98 | $0.21 | · | $2.64 | $4.77 | $9.54 | · | $1.14 | |
| EPS (TTM) | $7.46 | $-2100.09 | · | $-1773.16 | $-1700.49 | $-358.12 | · | $-906.08 | $-1042.58 | $-378.41 | · | $-160.39 | $-133.84 | $-46.86 | · | $-402.11 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | $9M | · | $8M | $8M | $9M | · | $9M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Net Income TTM | $-11M | $-19M | · | $-17M | $-15M | $-10M | · | $-15M | $-21M | $-18M | · | $-17M | $-17M | $-17M | · | $-17M | |
| Market Cap | $2M | $3M | · | $5M | $5M | $173M | · | $93M | $109M | $3.60B | · | $3.92B | $7.37B | $8.62B | · | $836.48B | |
| P/E | 0.4 | -0.0 | · | -0.0 | -0.0 | -0.1 | · | -0.1 | -0.2 | -1.4 | · | -13.1 | -29.5 | -152.5 | · | -197.4 | |
| P/S | 0.2 | 0.3 | · | 0.6 | 0.6 | 19.7 | · | 10.4 | 12.1 | 404.6 | · | 452.9 | 887.6 | 1021.3 | · | 106611.7 | |
| P/B | -0.9 | 1.0 | · | 1.2 | -0.5 | 48.3 | · | 29.4 | -15.9 | 4067.0 | · | 499.9 | 665.7 | 631.0 | · | 59680.0 | |
| P / Tangible Book | · | 1.1 | · | 1.2 | · | 48.3 | · | 29.4 | · | 4067.0 | · | 499.9 | 665.7 | 631.0 | · | 59680.0 | |
| P / Cash Flow | · | -0.9 | · | · | · | -68.1 | · | · | · | -1257.6 | · | · | · | -1412.1 | · | · | |
| Earnings Yield | 244.6% | -200008.6% | · | -52930.2% | -18403.6% | -907.1% | · | -1812.9% | -493.5% | -71.5% | · | -7.6% | -3.4% | -0.66% | · | -0.51% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $8M | $9M | $9M | $9M | $8M |
| Brüt Kâr Marjı % | 62.0% | 64.9% | 56.2% | 55.7% | 56.7% |
| Faaliyet Kâr Marjı % | -134.3% | -125.7% | -198.9% | -201.0% | -246.5% |
| Net Gelir | $-18M | $-11M | $-20M | $-15M | $-20M |
| Seyreltilmiş Hisse Başı Kâr | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 1.7 | 3.5 | 2.6 | 4.9 | 8.5 |
| Cari Oran | 0.9 | 2.7 | 1.8 | 4.1 | 7.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-11M | $-10M | $-18M | $-15M | $-18M |
Kurumsal Sahipler (13F)
Kurumsal faaliyet — Q1 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 2 (-1 önceki Ç'ye göre) | 3 (+3 önceki Ç'ye göre) | 3 (0 önceki Ç'ye göre) | 1 (-1 önceki Ç'ye göre) | +178K |
Q4 2025 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| ERB JOHN L | 16 Haziran 2025 | 7,30% | İlk başvuru | Pasif yatırım | SEC |
| Ki Yong Choi IRS Identification Nos. of Above Persons (Entities Only) ×5 başvurular | 20 Eylül 2017 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 35 içeriden öğrenenler · 20 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| ERB JOHN L | CEO and President | 27 Haziran 2025 A | 1.100.022 | 0 | 0 | $0 |
| Nestor Jaramillo Jr. | President and CEO | 15 Mart 2023 P | 4.098 | 0 | 0 | $0 |
| David A Rosa | Chief Executive Officer | 01 Ağustos 2015 F | 119.587 | 0 | 0 | $0 |
| Robert Benjamin Scott | Chief Financial Officer | 02 Eylül 2023 A | · | 0 | 0 | $0 |
| Lynn Larson Blake | Chief Financial Officer | 06 Ocak 2023 A | · | 0 | 0 | $0 |
| George Montague | CFO and Treasurer | 03 Mart 2022 A | · | 0 | 0 | $0 |
| Claudia Drayton | Chief Financial Officer | 22 Ocak 2021 A | 740 | 0 | 0 | $0 |
| Jeffrey S Mathiesen | Chief Financial Officer | 01 Ocak 2015 F | 37.223 | 0 | 0 | $0 |
| AYOTTE NEIL P | SVP, Secretary, GC & CCO | 03 Mart 2023 A | · | 0 | 0 | $0 |
| Thomas P. Lynch | Chief Legal Compliance Officer | 22 Ocak 2021 A | · | 0 | 0 | $0 |
| Jim Breidenstein | Chief Commercial Officer | 03 Ocak 2018 A | · | 0 | 0 | $0 |
| Molly Wade | Vice President | 15 Ocak 2017 F | 909 | 0 | 0 | $0 |
| Eric Lovett | VP, Clinical Affairs | 14 Ocak 2016 A | · | 0 | 0 | $0 |
| Brian Brown | SVP, Technology & Operations | 13 Ağustos 2015 P | 20.000 | 0 | 0 | $0 |
| Debra Kridner | Exec VP, Regulatory Affairs | 11 Ağustos 2015 P | 29.500 | 0 | 0 | $0 |
| Kimberly Oleson | SVP, Clinical Affairs | 01 Haziran 2015 F | 3.810 | 0 | 0 | $0 |
| William S Peters | CTO & Medical Director | 01 Ocak 2015 F | 33.309 | 0 | 0 | $0 |
| Jim Yearick | VP of Marketing and Sales | 08 Mayıs 2014 F | 10.153 | 0 | 0 | $0 |
| Kevin Bassett | Senior VP, Tech & Operations | 08 Mayıs 2014 F | 10.426 | 0 | 0 | $0 |
| Patrick Verta | Chief Medical Officer | 21 Ekim 2013 A | · | 0 | 0 | $0 |
| Archelle Georgiou Feldshon | Yönetim kurulu üyesi | 28 Nisan 2026 A | · | 0 | 0 | $0 |
| David Mcdonald | Yönetim kurulu üyesi | 28 Nisan 2026 A | · | 0 | 0 | $0 |
| Martin J Emerson | Yönetim kurulu üyesi | 28 Nisan 2026 A | · | 0 | 0 | $0 |
| Gregory D Waller | Yönetim kurulu üyesi | 28 Nisan 2026 A | 2 | 0 | 0 | $0 |
| Michael Kendrick Mccormick | Yönetim kurulu üyesi | 20 Mayıs 2025 A | · | 0 | 0 | $0 |
| Jon W Salveson | Yönetim kurulu üyesi | 19 Mayıs 2023 A | 42.492 | 0 | 0 | $0 |
| WATSON WARREN S | Yönetim kurulu üyesi | 19 Mayıs 2023 A | 42.492 | 0 | 0 | $0 |
| Steven Frank Brandt | Yönetim kurulu üyesi | 25 Mayıs 2022 A | 1.437 | 0 | 0 | $0 |
| Maria Rosa Costanzo | Yönetim kurulu üyesi | 03 Eylül 2019 J | · | 0 | 0 | $0 |
| Matthew E. Likens | Yönetim kurulu üyesi | 23 Mayıs 2019 A | 1.437 | 0 | 0 | $0 |
| Paul Buckman | Yönetim kurulu üyesi | 26 Mayıs 2016 A | 56.876 | 0 | 0 | $0 |
| Geoffrey Brooke | Yönetim kurulu üyesi | 29 Mayıs 2014 A | 7.855 | 0 | 0 | $0 |
| Nicholas Callinan | Yönetim kurulu üyesi | 14 Eylül 2012 P | 32.147 | 0 | 0 | $0 |
| Donal O'Dwyer | Yönetim kurulu üyesi | 17 Ağustos 2012 P | 52.466 | 0 | 0 | $0 |
| Choi Ki Yong | 10% sahip | 12 Ekim 2017 P | 1.793.109 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
NUWE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 6 analist
SAT
0 0,0%
Güçlü Al
0 0,0%
Al
3 50,0%
Tut
1 16,7%
Sat
2 33,3%
Güçlü Sat
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026